Global Policy Forum
Held in Barcelona, Spain, our annual Global Policy Forum took place January 27 to 29, 2019. This year’s theme was “Real-World Evidence in the Context of Health Technology Assessment processes – From Theory to Action” which spurred robust discussions from all those who attended. The Forum featured keynote presentations from Amy Abernethy, now principal deputy commissioner of the FDA, but who was representing Flatiron (a healthcare technology and services company), Andrew Mitchell representing the Pharmaceutical Benefits Advisory Committee (PBAC, Australia) and Andreas Hager as a patient representative. Four discussion themes were covered during the forum. These included:
- Quality and acceptability
- Governance and accountability
- Informing decision-making
To read the full newsletter, visit www.htai.org/policy-forum/. A peer reviewed article will also be appearing in the International Journal of Technology Assessment in Health Care (IJTAHC) soon; HTAi members get free access to the journal.
In addition, there will be a panel session at the HTAi Annual Meeting (Tuesday, 18 June, 3:15 pm) to report back and develop the discussions resulting from this year’s Global Policy Forum.
Latin America Policy Forum
Our next Latin America Policy Forum takes place in Bueno Aires, Argentina on from April 29-30, 2019. The discussion will be centered around ‘The link between HTA and decision making for resource allocation’. This Policy Forum will feature the regular two-day session but will be followed by a national workshop on HTA in Argentina in collaboration with the Argentinian Ministry of Health. Both the Policy Forum and the HTA workshop will feature opening remarks from the Argentinian Minister of Health.
For the first time we will also have a dedicated panel session (Wednesday, 19 June, 9:45 am) to report back on the discussions from this year’s Latin America Policy Forum at the HTAi Annual Meeting.
HTAi is proud to be participating in the 8th HTAsiaLink conference. Established in 2010 to strengthen collaboration between HTA agencies in Asia and Pacific region, the annual conference aims to be a capacity building platform for young researchers. HTAi President Sean Tunis and Vice President Inaki Gutierrez-Ibarluzea will both be delivering plenary speeches at the event. For more information please, visit https://htasialink2019.org/.
HTAi Public Health Interest Group
We are pleased to inform you about the merger of two existing Interest Groups at HTAi. The IG Initiatives for Public Health Outcomes Research and Measurement (INPHORM) and the IG Assessment of Vaccines Programs (AVP) will form a new ‘Public Health’ Interest Group (PH-IG). Public Health is a broad field which is rapidly expanding and attracting a high level of interest among policy makers and health authorities. As such, HTAi believes that this merger is a great opportunity to strengthen the HTAi capacity to:
- Align and collaborate more effectively on projects of common interest;
- Explore new activities and areas related to assessment of Public Health interventions;
- Allow greater Society engagement in the Public Health arena
We will be announcing the chair of this new Interest Group soon; please email firstname.lastname@example.org if you would like more information or want to be added to the mailing list.
The Public Health Interest Group business meeting will take place at the HTAi Annual Meeting in Cologne on Monday, June 17, from 12:45 to 1:45 pm.
HTAi Medical Devices Interest Group
We are pleased to inform you that HTAi have established a Medical Devices Interest Group. HTA plays an essential role in decision making and informing policy on the use of medical devices as a part of its broader scope for all technologies, as well as the efficient use of resources in health care.
The mission of the HTAi Medical Devices Interest Group (MD IG) is to promote and develop the interdisciplinary and multi-stakeholder assessments of medical devices and value-based healthcare in a consistent and comprehensive manner. The MD IG has the goal to produce relevant, objective research to inform and improve policy making that is intended to improve population health. The IG will advance the dialogue on Medical Device HTA methods and evidence based policy making. This will reflect all stakeholder groups and ensure the unique role of HTAi is considered in policy discussion.
Medical Devices Interest Group at HTAi Annual Meeting, Cologne:
Interest Group Business Meeting: Monday 17 June, 12.45-13.45pm
“HTA & Medical Devices: The Past, Present & Future of Medical Device Value Assessment”
Richard Charter, Sean Tunis, Rabia Kahveci, Aleksandra Torbica, Sally Lewis, Yves Verboven
Tuesday, 18 June, from 10:15 to 11:30 am
“Can HTAi support a shift to value-based health-care through new approaches for HTA of medical devices?”
Who: Rabia Kahveci, Richard Charter, Andrea Rappagliosi, Debjani Mueller, Oyvind Melien, Sean Tunis
Sunday, 16 June, from 1:00 to 4:30 pm
For further information regarding this newly established Interest Group please see our recent HTAi news post. If you would like any more information or would like to be added to a mailing list for this interest group, please email email@example.com.
Positions Available – Interest Group Chairs
We currently have two vacancies for Chair positions within our Interest groups. The HTAi Disinvestment and Early Awareness Group (DEA-IG) and HTA in Developing Countries Interest Group (DC-IG) are both currently looking for a new Chair. As Chair, you are responsible for leading the Executive Team and would be heavily involved the in planning and coordination of the Interest Group’s activities.
To learn more about the HTAi Disinvestment and Early Awareness Group (DEA-IG) position, click here.
For the HTA in Developing Countries Interest Group (DC-IG) position, click here.
Interested in learning more about our other Interest Groups? Visit www.htai.org/interestgroups to discover how you can get involved.